Home > Boards > US Listed > Medical - Healthcare >

Nanovibronix Inc. (NAOV)

NAOV RSS Feed
Add NAOV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/25/2020 3:09:47 PM - Followers: 7 - Board type: Free - Posts Today: 0

(NAOV) MC $27 Million /Shares Out 6.4 M / Float 1 M / 2 Products approved in US / 1 Potential Blockbuster expected to be approved in Q3 = 1000%+ UPSIDE on this unknown GEM...

NanoVibronix (NAOV)

Market Cap $27 Million
Shares Out 6.4Million
Price $4.10


i24 News Reports on the Effects of the PainShield (APPROVED IN US)
insert-text-here


UroShield: for the prevention of bacterial colonization and biofilm in urinary catheters


#Trial results compiled and expected 510(K) Class 2 filing to FDA in 1Q 2019

#Target FDA approval of 510K in 3Q 2019

#Projected target US launch in 3-4Q 2019



Product Pipeline:

UroShield: for the prevention of bacterial colonization and biofilm in urinary catheters.Currently CE Marked, an FDA De Novofiling for UroShield is anticipated in 1H 2019. If all goes to plan, the device could make its U.S. introduction later this year. The target market is big(24M indwelling catheters sold in the U.S. each year) and largely underserved (antibiotics are first-line treatment yet often prove to be ineffective)1. Indwelling catheter induced urinary tract infections are commonplaceand, given that they cost the healthcare system billions of dollars each year, hospitals have an economic interest to adopt novel technologies (potentially such as UroShield) that can prevent them.

PainShield: for the treatment of pain, muscle spasms and tendon diseases. The product has U.S. 510(k) clearance, CE Marking and Health Canada regulatory approval.At-home use for trigeminal neuralgia (TN), a neurological condition characterized by extreme pain along the trigeminal nerve in the face, is the main focused market for PainShield. First-line treatment oftrigeminal neuralgia, which causes such severe pain thatit has been called the suicide disease, are anticonvulsants. Surgery and opioids may also be used. While medications can be initially effective, their ability to control the disease usually wanes over time. Estimated U.S. incidence of TN isbetween ~40k and 140k. General soft tissue pain represents a less-defined but relatively enormous market and potent opportunity for PainShield, as does the recent crackdown on opioid overprescribing.

WoundShield: to speed the healing of hard-to-treat wounds.
WoundShield is CE Marked and has Health Canada approval. The chronic wound market is large and encompassesdiabetic foot ulcers (U.S. prevalence is ~5.5M with recurrence rate of 66%), venous leg ulcers (U.S. prevalence is ~600k with one-third recurring four or more times) and pressure ulcers (U.S. incidence of ~2.5M). An estimated $25B or more is spent each year on treating chronic wounds. While there are several modalities of advanced wound therapies available with varying degrees of effectiveness, almost all require operation by a trained clinician and a trip to the hospital. By contrast, WoundShield is designed for at-home use by an individual patient. Another potentially potent, and largely unique, advantage of WoundShield is the ability to use it as an adjunct, or complement, to existing advanced wound care modalities


LungShield: similar in form to UroShield but different in its application, LungShield is designed to reduce the risk of endotracheal infection in a hospital setting. It is currently being evaluated in a human pilot study in patients undergoing mechanical ventilation to determine its effect on development of bacterial colonies on endotracheal tubes

RenooSkin: to facilitate rejuvenationof facial skin.Unlike the NAOVs other products in which the transducer is enclosed in a patch or clip, RenooSkin consists of a head band-like applicator which houses two transducers near each ear. In vitro studies have indicated RenooSkin may be as effective as Retin-A (tretinoin, which generates ~$300M in annual sales)in its ability to rejuvenate skin. Target market is the non-prescription skincare space. Skin care is a very large market, generating ~$8B in annual sales in the U.S. Facial skin care is the fastest growing subcategory within skin care with sales of products such as facemasks, facial moisturizers and facial sprays increasing by as much as 39% annually


We recently met with the FDA and expect to file a 510(K) Class 2 filing in the first quarter of 2019. Towards this end, we have several smaller studies planned and underway we expect to include in our submission, which we believe will help support our application, including an animal model in sheep, a comparative study of leachables from a urinary catheter with and without UroShield attached, which is already underway, and a small study of patients with neurogenic bladder dysfunction. Given our past clinical data we are quite confident in our FDA submission and our goal is to receive marketing clearance in the U.S. by the third quarter of 2019, which we believe will be a major milestone for the Company. In the meantime, we are in active discussions with a number of potential partners in the U.S. and abroad, all of which should help drive value for shareholders.




Largest Shareholder:

AIGH Capital Management LLC 371,574    
Globis Capital LLC 326,902    
Kennedy Capital Management, Inc. 314,475    
Miriam Winder-Kelly 215,355
Sabby Capital LLC 199,776
IDT Corp. 155,838
AmTrust Financial Services, Inc. (Investment Portfolio) 146,148    
Harold Jacob, MD 89,840    
Jona Zumeris, PhD 68,879    
Brian M. Murphy 45,840 
  

NAOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NAOV News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 09/24/2020 04:16:36 PM
NAOV News: Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) 09/23/2020 06:01:37 AM
NAOV News: NanoVibronix Increases Previously Announced Bought Deal to $1.8 Million 09/22/2020 08:36:00 PM
NAOV News: NanoVibronix Announces $1.5 Million Bought Deal Offering 09/22/2020 06:11:00 PM
NAOV News: Current Report Filing (8-k) 09/22/2020 12:40:08 PM
PostSubject
#89   I’m in 76s looks good, huge potential . FROZENFLAME 09/25/20 03:09:47 PM
#88   think we will see a another dip after offering peterus 09/25/20 02:45:58 PM
#87   why does this stock keep dropping???? small float, 1hot toddy 09/25/20 02:43:50 PM
#86   BOUGHT MORE! xray168 09/25/20 02:43:43 PM
#85   0.77 on deck peterus 09/25/20 02:29:52 PM
#84   bought more .81... 0 volume as well... everything xray168 09/25/20 12:32:43 PM
#83   bought some 8s waiting 7...750s peterus 09/25/20 11:14:16 AM
#82   Great product line, current share price unbeatable. I blackhawks12 09/25/20 08:36:00 AM
#81   Good call on that 85s and 90.... close xray168 09/25/20 04:25:27 AM
#80   Still a great buy .91 here. Surprised!!! Added xray168 09/24/20 11:58:21 AM
#79   NAOV $$$ BACK TO $1.00+, THEN ONTO $3.00++.. halbroke1 09/24/20 10:52:15 AM
#78   yup i was right company was before on peterus 09/24/20 07:32:48 AM
#77   down to o.7s today? people lost fait is peterus 09/24/20 04:19:11 AM
#76   it was 1000% up on 140 mil peterus 09/24/20 02:06:34 AM
#75   Yes... probably closer to 11.3 million shares here xray168 09/23/20 05:53:51 PM
#74   Volume on DPI 333 mil. big difference KMBSOUTH 09/23/20 05:38:18 PM
#73   its a EV company it will fall back KMBSOUTH 09/23/20 01:29:23 PM
#72   it a pos look at SPI today o/s peterus 09/23/20 01:21:16 PM
#71   NAOV $$$ BIG GREEN EOD CLOSE TODAY..I LOADED halbroke1 09/23/20 01:21:03 PM
#70   people selling here for a big loss peterus 09/23/20 01:15:21 PM
#68   Only have 7k shares .965 average.... if .85 xray168 09/23/20 12:40:59 PM
#67   better wait 85s ...90s peterus 09/23/20 12:28:55 PM
#66   Yes. I’m fine buying .95 xray168 09/23/20 12:20:52 PM
#65   lol, maybe they made a "typo" in the GeorgeTheStub 09/23/20 11:19:18 AM
#64   Crazy it is Trading at under the offer KMBSOUTH 09/23/20 11:04:59 AM
#63   Well now. I got caught up here last GeorgeTheStub 09/23/20 10:25:01 AM
#62   2 mil traded in 7 mins KMBSOUTH 09/23/20 09:37:49 AM
#61   I dont have a premium account to mes. KMBSOUTH 09/23/20 09:23:53 AM
#60   I mean with computer trading yest. I think KMBSOUTH 09/23/20 09:22:12 AM
#59   I mean this stock held over 3 dollars KMBSOUTH 09/23/20 09:21:04 AM
#57   Yes at 1.00$. Getting under that is a xray168 09/23/20 09:03:35 AM
#56   $1.8M offering is nothing for FDA approved company. jwakstock 09/23/20 08:49:02 AM
#55   lol will be a red day NAOV peterus 09/23/20 07:10:04 AM
#54   NAOV $$$ LOOKING FOR A BIG DAY $2.00+...I'M LOADING.. halbroke1 09/23/20 06:27:05 AM
#53   looks like sh$t peterus 09/23/20 03:01:28 AM
#52   https://finance.yahoo.com/news/nanovibronix-announces-1-5-million-221100416.html Aarons 09/22/20 06:49:04 PM
#51   NAOV, wow trading under $1 now, wonder what GeorgeTheStub 09/22/20 05:59:58 PM
#50   I Bought in end of day... imho rocket tomorrow europtiger 09/22/20 04:43:01 PM
#49   * * $NAOV Video Chart 09-22-2020 * * ClayTrader 09/22/20 04:15:50 PM
#48   back out peterus 09/22/20 04:03:50 PM
#47   in 1.11s peterus 09/22/20 03:49:48 PM
#46   wow in 5min down 1.30...1.10s peterus 09/22/20 03:49:19 PM
#45   if it go down you have new bagholders peterus 09/22/20 03:44:06 PM
#44   looks like NAOV management should be required to GeorgeTheStub 09/22/20 03:43:59 PM
#43   and only at 1.30s should have run to $3+ peterus 09/22/20 03:25:39 PM
#42   I feel that was just a wash of KMBSOUTH 09/22/20 02:43:46 PM
#41   To say momo is dried up is far KMBSOUTH 09/22/20 02:42:04 PM
#40   Not thats public KMBSOUTH 09/22/20 02:36:08 PM
#39   Nothing has changed in this stock yo bring Aarons 09/22/20 02:24:09 PM
#38   Yup..momo drying up & offering could drop any 420man 09/22/20 02:20:48 PM
PostSubject
Consent Preferences